Home > Insider Trading > Filing (0000899243-22-024987)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1596946	Quotient Ltd	QTNT	In Vitro & In Vivo Diagnostic Substances (2835)	264719797

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1604877	Frederick Hallsworth	28 Esplanade St Helier Y9 JE2 3QA		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2022-06-30	80,808	$0.24	212,088	No	4	P	Direct
Ordinary Shares	Acquisiton	2022-06-30	4,000	$0.24	216,088	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Ordinary Shares	3,150	Indirect	By wife

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Ordinary Shares	Ordinary Shares Option (Right to buy)	$11.62		2025-10-31	7,505	7,505	Direct
Ordinary Shares	Ordinary Shares Option (Right to buy)	$8.00		2024-04-29	5,000	5,000	Direct
Ordinary Shares	Option to Purchase Ordinary Shares	$0.00	2014-02-13	2022-08-30	20,014	20,014	Direct
Ordinary Shares	Ordinary Shares Option (Right to buy)	$9.95		2024-10-31	5,025	5,025	Direct
Ordinary Shares	Ordinary Shares Option (Right to buy)	$5.73		2026-10-31	8,726	8,726	Direct
Ordinary Shares	Ordinary Shares Option (Right to buy)	$5.21		2027-10-31	9,597	9,597	Direct
Ordinary Shares	Ordinary Shares Option (Right to buy)	$6.41		2028-10-31	6,240	6,240	Direct
Ordinary Shares	Ordinary Shares Option (Right to buy)	$7.78		2029-10-31	8,158	8,158	Direct
Ordinary Shares	Ordinary Shares Option (Right to buy)	$4.55		2030-10-31	13,611	13,611	Direct
Ordinary Shares	Restricted Stock Units	$0.00			6,917	13,834	Direct
Ordinary Shares	Ordinary Shares Option (Right to buy)	$2.53		2031-10-31	24,040	24,040	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2025-10-31	7,505	7,505	Direct
2024-04-29	5,000	5,000	Direct
2022-08-30	20,014	20,014	Direct
2024-10-31	5,025	5,025	Direct
2026-10-31	8,726	8,726	Direct
2027-10-31	9,597	9,597	Direct
2028-10-31	6,240	6,240	Direct
2029-10-31	8,158	8,158	Direct
2030-10-31	13,611	13,611	Direct
	6,917	13,834	Direct
2031-10-31	24,040	24,040	Direct

Footnotes

Restricted Stock Units convert into ordinary shares on a one-for-one basis.
All 7,505 options have vested and remain exercisable.
All 5,000 options have vested and remain exercisable.
The exercise price will be paid in pounds sterling, at GBP0.91 per share.
All 5,025 options have vested and remain exercisable.
All 8,726 options have vested and remain exercisable.
All 9,597 options have vested and remain exercisable.
All 6,240 options have vested and remain exercisable.
2,719 options vested on October 31, 2021 and remain exercisable, and the remaining 2,720 options will vest on October 31, 2022.
All 13,611 options have vested and remain exercisable.
On October 31, 2021, the Reporting Person was granted 27,668 restricted stock units, of which 13,834 have vested and have converted into ordinary shares. The remaining 13,834 restricted stock units will vest in two equal installments on July 31, 2022 and October 31, 2022.
The options vest and become exercisable on October 31, 2022.